X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES

Content Team by Content Team
31st August 2019
in Manufacturing, Press Statements, Research & Development
Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Rentschler Fill Solutions GmbH, a contract development and manufacturing organization (CDMO) and expert for aseptic filling and finishing of biopharmaceuticals, received notification from the Austrian Agency for Health and Food Safety (Agentur für Gesundheit und Ernährungssicherheit, AGES) that the pharmaceutical manufacturing license for the European market and the certificate for GMP conformity will be extended for an unlimited period of time.

Rentschler Fill Solutions offers the international biotech and pharmaceutical industry specialist fill and finish services which range from GMP-compliant aseptic filling and freeze-drying to extensive analytics. The newly constructed, state-of-the-art facility went into operation in August 2018 and was initially certified by AGES for one year, as is common procedure. As part of a routine follow-up examination at the end of the first year of operation, the time limit has now been lifted.

This is an important milestone for the Company to support their clients in supplying vital drugs to clinics and patients.

Onsite, at the fully dedicated contract development and manufacturing organization, pharmaceutical and biopharmaceutical products are filled in vials of 2 to 50 ml for clinical and commercial use. The facility is designed for the flexible handling of small to medium sized batches of up to 60,000 vials and provides lyophilization capacity of 15m². Single-use equipment guarantees maximum product safety. Clients profit from comprehensive in-house testing, monitoring and analytics. The facility is designed to enable future expansion without interrupting ongoing operations.

About Rentschler Fill Solutions GmbH
Rentschler Fill Solutions GmbH, located in Rankweil, Austria, is a contract development and manufacturing organization (CDMO) for the aseptic filling of liquid and lyophilized pharma­ceutical and biopharmaceutical products. With their complete focus on clients’ projects, the company provides state-of-the-art facilities which comply with the latest regulatory, quality and safety standards. Rentschler Fill Solutions focuses on delivering small to medium-sized batches, up to 60,000 vials, to meet clinical and market needs with its highly scalable solutions. Owned by the Rentschler family, Rentschler Fill Solutions is a company with a highly skilled team offering extensive experience and reliable services in aseptic filling. For further information, please visit www.rentschler-fill-solutions.com.

About the Austrian Agency for Health and Food Safety (AGES)1
The Austrian Agency for Health and Food Safety (Agentur für Gesundheit und Ernährungs­sicherheit, AGES) is owned by the Austrian Federal Ministry of Labour, Social Affairs, Health and Consumer Protection and the Austrian Federal Ministry for Sustainability and Tourism. AGES provides professional and independent scientific expertise in questions relating to public health, animal health, food safety, medical and drug safety, food security and consumer protection. More information can be found here: www.ages.at.

Previous Post

ADC Therapeutics and Freenome Enter Biomarker Development Collaboration

Next Post

Zogenix Announces Acquisition of Modis Therapeutics, Inc.

Related Posts

Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
wearable drug delivery devices
Insights

Wearable Drug Delivery Devices for On-Demand Care

27th September 2025
Next Post
Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

Zogenix Announces Acquisition of Modis Therapeutics, Inc.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In